Recent studies describe beneficial effects of bone marrowderived mesenchymal stem cell infusion in animal models as well as in patients. However, data on the homing abilities of primary and culture-expanded MSC are lacking. In order to systematically investigate MSC homing we compared the fate of both primary and cultured MSC in a syngeneic mouse model. Twenty-four hours after transplantation of uncultured EGFPtransgenic MSC into sublethally irradiated mice, as many as 55-65% of injected CFU-F were recovered from the BM and 3.5-7% from the spleen. In the subsequent 4 weeks these donor CFU-F expanded 100-fold, which resulted in a normalization of femoral and splenic CFU-F numbers. This highly efficient homing of primary CFU-F contrasted with the defective homing of MSC following culture. Following their infusion immortalized multipotent syngeneic stromal cells were undetectable in BM, spleen, lymph nodes or thymus. Remarkably, following transplantation of primary MSC that had been cultured for only 24 h the seeding fraction in the BM was reduced to 10%, while after transplantation of 48 h cultured primary MSC no CFU-F were detected in the lymphohematopoietic organs. These data suggest that in vitro propagation of BM-derived MSC dramatically decreases their homing to BM and spleen.
Introduction
The bone marrow (BM) is the preferred site where the most primitive hemopoietic stem cell populations are maintained in order to give life-long production of functional blood cells. The marrow stroma is a heterogeneous mixture of cells including adipocytes, endothelial cells, reticular cells, fibroblastic cells and smooth muscle cells, which provide growth factors, cytokines and chemokines as well as a physical matrix. It has been well established that the stroma contains progenitors that in vitro can give rise to bone, cartilage, adipose tissue, tendon, smooth-, skeletal-and cardiac muscle, early progenitors of neural cells and a phenotype that supports hematopoietic differentiation. [1] [2] [3] [4] [5] [6] [7] As these cells are from mesenchymal origin their common precursors are referred to as mesenchymal stem cells (MSC) or marrow stromal cells. 8, 9 MSC were first identified in vitro by Friedenstein et al, 10 who referred to them as fibroblast colony-forming units (CFU-F). He showed that a population of BM cells plated in serumcontaining medium would give rise to colonies of adherent cells with fibroblast-like characteristics, that could differentiate to osteoblasts and adipocytes. This multipotent differentiation potential of MSC has also been demonstrated in vivo. 11, 12 It has been reported that local and even intravenous infusion of cultured MSC ameliorates the disease condition in children with Osteogenesis imperfecta, 13, 14 rats with brain insults 15 and mice with infarcted myocardium. 16 In addition, recent publications in xenogeneic bone marrow transplantation models have shown that co-infusion of MSC enhances the hematopoietic recovery of a human marrow graft in xenogeneic recipients. 17, 18 There are only few reports on transplantation and homing of MSC in a clinical setting. Although most of these could not detect donor cells, [19] [20] [21] [22] two studies using sex-mismatched allografts showed that donor-type containing stromal layers could be retrieved from the BM in 14 out of 41 patients 23 and four out of 14 patients. 24 It should, however, be noted that no specific MSC assays were done while total (T cell-depleted) bone marrow was used, consequently, these donor type cells could have originated from cells of non-mesenchymal origin.
In the first experiments reported, using donor cells carrying chromosomal abnormalities or sex-mismatched transplantations, only some investigators, including our own laboratory, could demonstrate homing and engraftment of donor-derived MSC 25, 26 whilst others were unsuccessful in doing so. [27] [28] [29] In more recent studies, applying gene-tagged cells in a murine transplantation model, donor-derived MSC were detected in a broad range of tissues by sensitive PCR. 30, 31 Also, using xenogeneic models, human MSC could be detected 7 weeks after transplantation in the NOD/SCID model 32 and for as long as 13 months following in utero transplantation in fetal sheep. 11 Whilst these papers clearly demonstrate that MSC are able to home to and persist in the lymphohematopoietic organs, all analyses were done in a qualitative or semi-quantitative manner. As a consequence, these studies do not give insight into the actual numbers of donor-derived MSC present in the various organ systems. A further complication is that in most of these studies culture-expanded MSC were used, which might show an aberrant in vivo homing or expansion.
We therefore examined, in a quantitative manner, the homing, in vivo expansion and tissue distribution of both cultured and uncultured bone marrow-derived MSC, using a syngeneic mouse model and primary and secondary CFU-F assays to quantitate the numbers of MSC in bone marrow, spleen, thymus and lymph nodes.
Materials and methods

Animals
All normal animals used were 10-12-week-old female C57Bl/6N Crl Br mice obtained from Charles River Laboratories (Maastricht, The Netherlands). Enhanced green fluorescent protein (EGFP)-transgenic C57Bl/6J mice (strain: C57BL/6TgN(ACTbEGFP)1Osb), in which EGFP is under the control of the chicken ␤-actin promoter, were obtained from the Jackson Laboratory (Bar Harbor, ME, USA) and housed and bred in our Animal Facility. As not all of the tissues in these mice express EGFP at sufficiently high levels to allow 161 for detection by fluorescence microscopy we tested the suitability for our experiments by evaluating the EGFP expression in CFU-F-derived colonies. All EGFP-transgenic CFU-F expressed EGFP at levels high enough to allow for easy discrimination between EGFP-positive CFU-F and the background fluorescence of non-EGFP CFU-F. Animals were housed under specified pathogen-free conditions, using laminar airflow units. Both food and water were available ad libitum. Housing, care and all animal experiments were done in accordance with Dutch legal regulations, which includes approval by a local ethical committee.
Isolation and long-term culture of mesenchymal cells
Mice were killed by cervical dislocation and femora and tibiae isolated. After dissection of attached muscle and connective tissue from the bones, the marrow was extruded by clipping of the epiphysial ends of the bones and flushing using a 26-gauge needle with 2 ml of Iscove's modified Dulbecco's medium (IMDM, Gibco, Breda, The Netherlands), supplemented with 20% heat-inactivated fetal calf serum of a preselected batch (Summit Biotechnology, Fort Collins, CO, USA), ␤-mercaptoethanol (5 × 10 −5 mol/l), penicillin (100 U/ml) and streptomycin (100 g/ml) (MSC medium). Single cell suspensions were prepared from the marrow plugs by resuspending the cells using a syringe mounted with a 19G needle, and passing them through a 100 m cell strainer (Falcon, Micronic, Lelystad, The Netherlands).
To remove the hematopoietic cells and to prevent overgrowth of the cultures with macrophages, the bone marrow suspension was depleted from CD45 + cells by negative immuno-magnetic cell selection using the AutoMACS device (Miltenyi Biotec, Bergisch Gladbach, Germany). Briefly, bone marrow cells (BMC) were resuspended in MACS-buffer (PBS + 1% FCS + 2 mM EDTA) and stained for 30 min on ice with cychrome-labelled rat-anti-mouse-CD45 (BD Pharmingen, Alphen a/d Rijn, The Netherlands). Following labelling cells were washed with MACS buffer and resuspended in MACS buffer at a concentration of 10 7 cells/40l, after which the BMC were incubated for 20 min at 4°C with 10 l of paramagnetic beads (goat-anti-rat-Ig-microbeads; Miltenyi Biotec) per 10 7 cells. After two washes with MACS buffer cells were finally resuspended in this buffer at a concentration of 10 8 cells/ml and depleted from CD45 + cells using the sensitive depletion program of the AutoMACS. To assess the purity of the depleted fraction, samples obtained before and after depletion of the CD45 + cells were analyzed by flow cytometry using a FACScan flow cytometer (Becton Dickinson Immunocytometry Systems, San Jose, CA, USA). Before selection around 95% of the BMC expressed CD45, whilst after depletion this percentage was reduced to around 8-10% with most of the CD45 + cells within this population expressing CD45 at only a low density (data not shown).
The resulting CD45-depleted BMC were cultured at 37°C and 10% CO 2 in a humidified atmosphere at a density of 10 4 cells/cm 2 in T75 Culture flasks (Falcon) in MSC medium with weekly medium changes. When adherent cells reached 80% confluence cells were isolated by treatment with 0.25% trypsin/EDTA (Gibco) and replated at 10 4 cells/cm 2 . From these cultures we generated two cell lines, designated MBM45-1 and MBM45-2, which we used for further analysis.
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Viral vectors and transduction of cell lines
Supernatants containing the EGFP retroviral vector were generated by culturing approximately 80% confluent monolayers of the amphotropic retroviral producer cell line MFG-EGFP 33 for 24 h in MSC medium. The cultures were maintained at 37°C with 10% CO 2 in a humidified atmosphere. The culture supernatant was collected and passed through a 0.45 m filter in order to remove remaining cells.
The virus supernatant was subsequently used to transfect BM-derived adherent cells. To enhance the transduction efficiency of the adherent cells, T-25 culture flasks (Costar no. 3055, Cambridge, MA, USA) were coated with recombinant fibronectin fragment CH-296 (Takara Shuzo, Otsu, Japan) at a concentration of 10 g/cm 2 as described previously. 34 Before adding the target cells to the precoated flasks the fibronectin fragments were preloaded with virus by preincubation with the virus supernatant for 1 h at 37°C. Subsequently the target cells were resuspended in the virus containing supernatant and added to the flasks (10 4 cells/flask), after which the cultures were maintained at 37°C and 10% CO 2 in a humidified atmosphere with daily replacement of the medium with fresh virus supernatant until 80% confluence (generally 4-5 days). Finally, the cells were harvested after which part of the cell suspension was used for analysis of the transduction percentage using flow cytometry and the remainder replated in a T75 culture flask (Falcon) for further expansion.
CFU-F assay
To assess the numbers of CFU-F in suspensions of BMC or the generated cell lines, cells were plated in a semi-solid medium consisting of IMDM, 20% of our pre-selected FCS batch and 0.8% methylcellulose (Methocell MC, Fluka Biochemika, Buchs, Switzerland) into Falcon 3001 culture dishes (35mm diameter) and incubated for 10 days at 10% CO 2 and 37°C.
The addition of methylcellulose to the cultures, as originally described by Brockbank et al, 35 has the benefit of strongly reducing the outgrowth of contaminating macrophages. To test the validity of this assay we compared the original assay as described by Friedenstein et al 10 with the modified method. In both assays equal numbers of CFU-F were observed. We also checked for the presence of contaminating macrophage colonies by means of staining with anti-CD45 and the macrophage-specific F4/80 mAb. In general, less then 1% of the colonies was CD45 + F4/80
On some occasions individual hematopoietic cells or macrophages could be observed in contact with otherwise negative fibroblastiod colonies (data not shown).
For the enumeration of donor-type colonies, ie colonies derived from EGFP-transgenic mice or EGFP-transfected cultures, colonies were visualized through an inverted fluorescence microscope using a standard FITC filter set. To enumerate host-type, ie non-fluorescent colonies the dishes were washed twice with ice-cold PBS to remove the methylcellulose from the dishes, after which the cells were fixed with methanol (10 min, room temperature). This was followed by a staining of the CFU-F with a 1:10 dilution of Giemsa (Sigma) in Sö rensen-buffer. After a final rinse in tap water, colonies were counted using a standard inverted microscope. As this stains both host-and donor-type colonies the actual number of host-type colonies was derived by subtracting the number of EGFP-positive colonies from the total number of colonies. Both for the EGFP and non-EGFP samples clusters of cells Leukemia were considered to be a colony if they contained 50 or more fibroblastoid cells.
Differentiation assays
To verify the multipotential mesenchymal characteristics of our generated cell lines, cells were analyzed for osteogenic, adipogenic, myogenic and chondrogenic potential. 36, 37 Before inductive media were added, cultures were grown to confluence after which the standard MSC medium was replaced with the inductive media.
To induce osteogenic differentiation cultures were daily fed with MSC medium to which was added 10 mM ␤-glycerophosphate, 50 g/ml ascorbic acid and 10 −9 M dexamethason for up to 3 weeks. Mineralization of the extracellular matrix was visualized by staining of the cultures with Alizarin Red S (2% w/v Alizarin Red S adjusted to pH 4.1 using ammoniumhydroxide) for 5 min at room temperature followed by a wash with water.
Adipogenic differentiation was induced by passaging cells at a 1:10 dilution in MSC medium + 5 g/ml insulin and 10
M dexamethasone. Adipogenic differentiation was visualized by the presence of highly refractive intracellular lipid droplets in phase contrast microscopy.
Myotube formation was induced by the addition of 1.5 g/ml amphotericin B (fungizone; Gibco) to the culture medium for approximately 2-3 weeks followed by withdrawal of the fungicide after which the cells were cultured for another 1-2 weeks.
Chondroblast differentiation was induced by harvesting the cells by trypsinization after which 5 × 10 6 cells were pelleted on the bottom of a well from a 96-well round-bottom cluster plate (Falcon). To this pellet 50 l of MSC medium was added and, after an overnight incubation, another 50 l of MSC medium containing 50 g/ml ascorbic acid and 1 ng/ml TGF-␤1
(Peprotech, Sanvertech, Heerhugowaard, The Netherlands). After 2-3 weeks of culture cell clumps were harvested, washed in 1% acetic acid and stained for glycosaminoglycans using 0.1% Safranin O.
Flow cytometry
To determine the antigen expression profile of the BM-derived adherent cells, the cell lines (passage No. 15) were harvested by trypsinization for 5 min after which cells were pelleted at 1000 g for 8 min. Pellets were washed and resuspended in PBS+1% FCS+0.1% sodium azide at a density of around 2 × 10 6 cells/ml. Fifty l aliquots of this suspension were then transferred to individual tubes and labelled for 30 min on ice with the appropriate dilution of one of the following antibodies: CD11a, CD31, CD62L, CD62P, Flk-1 (all FITC-labelled, purchased from Beckman Coulter, Mijdrecht, The Netherlands), CD44, CD45,CD105,CD106 (also FITC-labelled, BD Pharmingen), CD18, CD54, CD117 (all PE-labelled, Beckman Coulter), CD9, CD90, CD126, CD135 and CD138 (also PE-labelled, BD Pharmingen). After staining the samples were diluted to 500 l with PBS+1% FCS+0.1% sodium azide to which 3 l of 7-amino-actinomycin D (7-AAD; Molecular Probes, Leiden, The Netherlands) was added to allow for the exclusion of dead cells. Cells were measured on a FACScan cytometer (Becton Dickinson) and analyzed using the CellQuest software package (Becton Dickinson).
Transplant procedure
Recipient animals (C57Bl/6N Crl Br) of either cultured cells or primary BMC were conditioned by 7 Gy total body irradiation the day before transplantation ( 137 Cs gammasource, Gammacell; Atomic Energy of Canada, Ottawa, Canada). Cells were transplanted by injection of 0.2 ml of the cell suspension in the lateral tail vein. To determine the input number of CFU-F, a sample of this cell suspension was assayed in the CFU-F assay. At indicated time points groups of three mice were killed by cervical dislocation after which femora, spleen, thymus and inguinal lymphnodes were isolated, single cell suspensions prepared and the number of CFU-F assayed. The total BM CFU-F content was calculated on the assumption that one femur is equivalent to 1/16th of the total BM of a mouse.
Results
Host conditioning
In analogy to the situation in the hemopoietic stem cell compartment, the availability of suitable niches for MSC to home to following their systemic infusion might determine both their homing efficiency, their ability to expand their numbers in the target organs as well as their long-term contribution to the host MSC compartment. In order to investigate this thesis, we have first investigated the depletion of the CFU-F compartment in the BM of the putative recipient mice at 24 h following total body irradiation (TBI, Figure 1 ). The data indicate an increasing loss of CFU-F-derived colony formation with increasing radiation dose. From these data the estimated D 0 of CFU-F is 1.3-1.4 Gy, which suggests a somewhat higher radiosensitiv-
Figure 1
Dose-response curve of the effect of total body irradiation on the femoral CFU-F content in C57Bl/6 mice. Twentyfour hours after the C57Bl/6 mice received graded doses of total body irradiation the femoral CFU-F content was assayed and a trendline fitted. Using this line the in vivo D 0 for the femoral CFU-F was estimated to be 1.3 to 1.4 Gy. Each point depicted in this figure is the mean ± 1 s.e.m. of three individually assayed mice. Femoral CFU-F levels in unirradiated mice were on average 900 CFU-F/femur. ity of BM CFU-F in C57BL mice as compared to some other mouse strains. 25, 38 
Homing and in vivo expansion of primary MSC
In a series of three experiments, we investigated the homing and expansion of primary, EGFP-marked, MSC into the lymphohematopoietic organs (ie BM, spleen, thymus and lymph nodes) of recipient mice that were either not irradiated, or received 3 or 7 Gy TBI. Data of a representative experiment are shown in Figure 2 . In these experiments mice were transplanted with 3-5 × 10 6 uncultured BMC containing 110-350 CFU-F. In unirradiated recipients only 15 ± 5 donor CFU-F were retrieved from the total BM at 24 h post-infusion, ie 4.3 ± 1% of all infused CFU-F had homed to the BM (Figure 2a) . In these groups, the number of donor CFU-F showed a limited increase until day 7 post-transplant after which they declined until they were no longer detectable at day 15. At difference with these observations, a highly efficient homing was observed in 3 and 7 Gy TBI recipients, where 41-53% of the transplanted CFU-F were retrieved from the total BM. The rapid and complete recovery of the total BM CFU-F content within a months time, with about a two-fold higher content of donor CFU-F in the 7 Gy TBI group as compared to the 3 Gy TBI group, was mainly the result of donor CFU-F expansion.
In 7 Gy TBI hosts, endogenous CFU-F (Figure 2c ) regenerated only 6.4 ± 3% of the total BM compartment, while full host CFU-F regeneration in the BM of 3 Gy TBI recipients was observed despite the contribution of donor-type CFU-F.
The number of initially seeded donor-derived CFU-F in the spleen of unirradiated mice (Figure 2b) showed an even more rapid decline when compared to the BM and after 7 days no donor-derived CFU-F could be observed in the spleens of any of these animals. In the 7 Gy preconditioned groups the 24 h homing of donor CFU-F to the spleen was 5 ± 5% of infused CFU-F and these quickly expanded so that almost 100% of the spleen CFU-F content was donor type at day 7 posttransplantation.
In general, the levels of donor-derived CFU-F in the BM and spleen remained more or less stable from around week 4 to at least week 10 post-transplant, the latest time point analyzed (data not shown). In the thymus no donor CFU-F could be detected at any of the observation points while only an occasional donor CFU-F was observed in the lymph nodes. As the numbers of recipient CFU-F within these organs were also borderline detectable no further calculations were performed.
In summary, these observations indicate that a modest TBI dose of 3 Gy is sufficient to ensure a high homing efficiency and regeneration of donor CFU-F in both BM and spleen.
On the basis of our data we could calculate donor CFU-F chimerism (Figure 2e and f) following 7 Gy TBI in the host BM and spleen. In the first days after transplantation, donor CFU-F chimerism was close to 100% and it slowly decreased to 93% in BM and 85% in the spleen. In 3 Gy TBI hosts, donor CFU-F chimerism increased to 50% during the first week posttransplant in the BM after which it remained constant, while it increased to 90% in the spleen before it levelled off to values ranging between 50 and 64%. This rapid increase in the numbers of donor-derived splenic CFU-F during the first week following transplantation suggests that migration of CFU-F from other organs complemented the local donor-CFU-F regeneration.
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Homing of culture-expanded mesenchymal stem cells
Although the experiments described above show that primary bone marrow-derived MSC, detected as CFU-F, are able to efficiently home and expand in both spleen and bone marrow, most therapeutic applications will make use of cultured MSC. We therefore generated two C57Bl/6 derived 'MSC-like' cell lines, designated MBM45-1 and MBM45-2, and used these for in vivo homing studies. Both lines were independently established from CD45-depleted bone marrow. These highly proliferative adherent cell lines showed a CFU-F frequency of 1:2 to 1:3. When plated at low density, based on morphology, three distinct types of cells could be observed within these cultures ie small spindle-shaped fibroblastoid cells (Figure 3a) , medium-sized flattened irregular shaped fibroblasts ( Figure  3b ) and large more or less rounded cells often showing a multi-nucleated appearance (Figure 3c ).
Both cell lines were further characterized for phenotype and in vitro differentiation capabilities. As depicted in Table 1 , immunophenotypic analysis by FACS showed these cell lines to be negative for the hematopoietic marker CD45 and to express a broad range of adhesion molecules. CD105, also known as SH2, which is considered to be one of the hallmark antigens for MSC, 39, 40 was expressed together with CD90, SCA-1 and CD9 at a particularly high level in both cell lines. We also investigated the mesenchymal multilineage differentiation potential of both the MBM45-1 and MBM45-2 cell lines into adipocytes, chondrocytes, osteoblasts and myotubes. Except for the formation of chondroblasts all other differentiation lineages could be detected in our cultures ( Figure 4 and Table 2 ), albeit in different frequencies.
As both cell lines were derived from normal C57Bl/6 mice we had to tag them so as to be able to discriminate between them and the host-derived CFU-F in the secondary CFU-F assay used in the in vivo homing assay. We therefore transduced the cells with the gene for EGFP using supernatant of the amphotropic retroviral producer cell line MFG-EGFP. After the transduction procedure 95-97% of the cells were shown to be strongly EGFP positive as determined by flow cytometry. This expression was stable in vitro and CFU-F frequencies of both cell lines were unaffected by the transduction procedure.
In order to assay the in vivo homing ability of the cultured MSC we injected 100 and 1000 cells, equivalent to 45 and 450 CFU-F of either MBM45-1 or MBM45-2 into 7 Gy irradiated syngeneic recipients and assayed the number of EGFP + CFU-F in BM and spleen at 24 and 72 h after transplantation. In contrast to primary bone marrow MSC, no culturederived CFU-F could be detected in any of the mice both at the 24 and 72 h time points. From these results we could calculate that less then 4% of the cells homed to the entire bone marrow and less then 1% to the spleen.
Homing of short-term cultured MSC
Although both the MBM45-1 and MBM45-2 cell lines in vitro displayed MSC-like characteristics as multipotent differentiation and the ability to form CFU-F, we could not exclude the possibility that the prolonged culture of the cells had induced loss of the in vivo homing abilities of these cells either by differentiation or transformation of the cells. To study this possibility we investigated the in vivo homing ability of short-term, ie 24 Homing and expansion of primary donor bone marrow-derived MSC in bone marrow and spleen of syngeneic recipient mice. This figure depicts the data of a single representative experiment out of a series of three. C57Bl/6 mice, either unirradiated or having received 3 or 7 Gy TBI, were transplanted with an EGFP-transgenic bone marrow graft containing 384 ± 8 CFU-F per mouse. At indicated time points mice were killed and the numbers of donor-(panels a and b) and host (panels c and d)-CFU-F were determined in bone marrow and spleen. From the donor to host ratio the percentage of chimerism was calculated (panels e and f). Shaded areas indicate the normal ranges of CFU-F in bone marrow and spleen of unconditioned animals. Data are presented as the mean ± 1 s.e.m. of three individual mice.
and non-adherent cells were harvested separately and assayed for the in vivo homing of the mesenchymal stem cells (see Table 3 ). All cultures were initiated with 3.5 ± 0.3 × 10 7 BMC, containing 1250 ± 141 CFU-F. Both after 24 and 48 h of culture the total percentage of CFU-F recovered in the adherent and non-adherent (NA) fractions (ie 61.5 and 73.4% of input, respectively) was reflecting the percentage of nucleated cells recovered (ie 70.5 and 74.1%). Surprisingly, most recovered CFU-F were present in the NA fraction of the cultures. After 24 h of culture 91% (ie 695 of 763 CFU-F) of the total number of CFU-F was recovered from the NA fraction whilst at 48 h of culture this fraction still contained 75% (ie 693 of 923) CFU-F. The determination of the 24 h homing of cultured cells was hampered by the limited number of green (donor) fluorescent CFU-F detected. We therefore allowed some CFU-F expansion in vivo to occur for 3 days to increase our detection sensitivity (see Figure 2) . Three days following the transplantation of these cells into 7 Gy irradiated recipient mice donor-
Figure 3
Photomicrograph of the morphology of the 'MSC-like' cell line MBM45-2 seeded at low density. MBM45-2 cells were plated at low density; after 1 week of culture the formed colonies were fixed and stained with Giemsa. In these cultures we could observe three distinct types of cells ie (a) small spindle-shaped fibroblastoid cells, (b) medium-sized flattened irregular shaped fibroblasts and (c) large, more or less rounded cells often showing a multinucleated appearance (indicated by the arrows). In the cultures, colonies of the small spindle shaped cells were most abundant whilst the large, multinucleated cells were the most rare cells. The latter cell type was always observed in association with colonies of the spindleshaped cells.
Leukemia derived CFU-F could only be detected in the bone marrow of animals transplanted with the NA fraction of 24 h cultured bone marrow (Table 3) . The low percentage (10% of input) of CFU-F recovered in the bone marrow indicates that the NA fraction of 24 h cultured BMC had considerable lower seeding abilities as compared to uncultured bone marrow cells.
Discussion
Our current study clearly demonstrates that primary BMderived MSC (assayed as CFU-F) upon their injection into sublethally irradiated hosts show a highly efficient seeding to the bone marrow and spleen, ie 24 hour post-transplant 55-65% of all infused MSC could be recovered from these organs. This high seeding efficiency compares favorably with the approximately 25% hemopoietic stem/progenitor cells homing to these organs in a murine model. 41, 42 At 24 h after their transplantation, no donor-derived MSC could be detected in other lymphohemopoietic organs such as thymus and inguinal lymph nodes, while only at later time points could some donor MSC be retrieved from the inguinal lymph nodes. The data show that conditioning of the host by irradiation increased the MSC seeding remarkably, and especially the outgrowth of the donor MSC in the bone marrow and spleen of the hosts and their contribution to the regeneration of the MSC compartment to pre-irradiation levels. We were, however, not able to study the anatomical distribution of injected MSC in the target organs as currently no methods exist for obtaining a 100% homogenous primary murine MSC population. The rapid regeneration of the BM and splenic MSC content by donor MSC in irradiated mice is at difference with our earlier data in CBA/N mice, where the donor cells were derived from CBA/T6T6 mice with a chromosomal trisomy. 25 Although we observed similar high seeding efficiencies of donor CFU-F in the host BM at 24 h post-transplantation in irradiated recipients, 43 the subsequent restoration of BM CFU-F content was slow and incomplete after a year. Only following treatment of the recipients with 150 g LPS-W i.v. at 3 months post-TBI and bone marrow transplantation was a rapid normalization of CFU-F content observed. 44 We postulated that whilst the radiation reduces the host CFU-F colony-forming ability in vitro, it did not physically kill the cells and left them alive and functional in their niche. This situation would have led to a lack of need to replace these cells by donorderived CFU-F. In this model, LPS induced a physical depletion of the host-CFU-F/stromal cells thus creating the niches for the donor-derived cells to home to and engraft, as well as to allow some radioresistant host-CFU-F to regenerate. The observed differences are unexplained at the moment, but could be due to the different mouse strains used.
Our observation that MSC chimerism in BM and spleen was relatively stable may suggest that donor and host cells competed with equal strength for the niches in these organs. However, we observed that an average of 88 host MSC survived in the total BM on day 1 post-transplantation, whereas an average of 263 donor MSC were infused, 50% of which homed to the total BM, ie 132. Thus, as the initial ratio of donor:host MSC on day 1 post-transplant was 132:88, 60% donor chimerism was expected after regeneration. This contrasted with the 85-99% donor chimerism observed. It is evident from our present work that not the day 1 post-transplant host MSC values but rather those of day 3 represent the nadir of the radiation effect, thus accounting for a delayed regeneration of host MSC. However, donor MSC do not show this Table 1 Phenotypic characterization of the mesenchymal stem cell lines MBM45-1 and MBM45-2 Name Marker alternative name Expression level
Ly6A/E ++++ ++++
Cells were harvested by trypsinization of the cell lines. The resulting single cell suspensions were labelled with fluorescently labelled antibodies against the indicated surface markers and analyzed using flow cytometry. All cells analyzed behaved as a single population, ie the whole population was positive or negative, only the expression levels of the markers varied. The expression level of the markers was scored as: −, no expression detected; −/+, only a small peak shift observed when compared to the control; +, expression was in the first decade of control, ++, expression was between one and two decades higher than control; +++, expression two to three decades higher than control; ++++, expression more than three decades higher then control.
delay and immediately increase their numbers. This then would result in higher percentages of donor chimerism than could be expected on the basis of equal competition of surviving host and homed donor MSC. In contrast to our data, in most studies where primary BMC were infused, as in clinical transplantations, donor-type fibroblasts or MSC either could not be detected [19] [20] [21] [22] or be detected only in a part of the recipient group. 23, 24 It is likely that this discrepancy can be fully explained by the fact that these studies concern allogeneic transplantations rather than syngeneic, as in our model. To date, little is known about the immunogenicity and graft rejection in MSC transplantation. In a series of preliminary experiments comparing syngeneic and allogeneic transplantation, using equal MSC graft sizes, we observed similar high levels of engraftment using a MHCmatched model whilst in an MHC-mismatched model merely short-term repopulation of CFU-F was observed (data not shown). It should also be noted that before transplantation bone marrow grafts generally undergo different forms of processing. As we have shown for density gradient separation 45 this processing could very well influence the number of MSC present in the grafts.
There is ample data to suggest that most infused MSC are sequestrated in the body's capillary beds, especially those of liver and lungs, after their infusion, and only few end up in the bone marrow, or bony tissues. However, most of the experimental studies concern culture expanded 11, 17, 31, 46 or genetically tagged 1, 30, 32, 47 stromal cells which were infused in recipients either without preconditioning or following a variety of conditioning regimens (mainly different regimens of TBI). As an example, Gao et al 48 injected cultured and Indiumlabelled rat BM-derived MSC into syngeneic recipients and monitored by real-time imaging their distribution in the body. The majority of the infused MSC were detected in liver and lungs, while only very few were observed to have homed to bones and spleen. We show here that only 1 day of culture dramatically decreased the seeding efficiency of MSC in BM and spleen, whereas after 48 h no donor MSC could be detected in these organs. The reduced numbers of CFU-F recovered after in vivo passage were not due to the loss of MSC during culture, as we retrieved 61 and 74% of the input CFU-F, respectively, after 24 and 48 h of in vitro incubation. Similarly, if we transplanted the EGFP-tagged cell lines MBM45-1 and MBM45-2, no cells could be detected in BM, spleen, thymus or lymph nodes at any time point following their transplantation in vivo. Yet, one in two to three of these cells formed a fibroblastoid colony upon plating, while both cell lines were still multipotent in that they could differentiate into adipose, bone and smooth muscle cells in vitro. It could be argued that the cell dose of 1000 cells we injected was too low to allow for the detection of the seeded cells. However, the equivalent dose of 450 CFU-F in the uncultured conditions results in 180-225 CFU-F in the bone marrow 24 h post-transplant and finally completely reconstituted the donor CFU-F compartment, indicating that the seeding and expansion abilities of both MBM45-1 and MBM45-2 are at least severely impaired.
We can only speculate as to the extremely rapid decrease in MSC seeding efficiency in vivo following a brief or extended culture period in vitro. Also, hemopoietic stem cells have been reported to show a decreased long-term repopulating ability and CAFC content after only short-term in vitro culture. [49] [50] [51] The most likely mechanism is the modulation of homing molecules, such as chemokine receptors or adhesion molecules, on MSC during their in vitro incubation, as has been shown to affect homing of HSC as well. 52, 53 Indeed, the loss of SH3, ICAM-1 and integrin␤1, and a decreased production of extracellular molecules has been reported to Photomicrograph of the in vitro differentiation of the 'MSC-like' cell line MBM45-2. MBM45-2 cells were cultured in differentiation inducing media as described in Materials and methods. Using either this cell line or the MBM45-1 cell line we could observe a trilineage differentiation towards: (a) adipocytes, as shown by phasecontrast microscopy; (b) osteoblasts, as shown by the formation of calcium rich hydroxyapatite in the extracellular staining orange-red with Alizarin red S; (c) myotubes, indicated by the arrows in this phase-contrast photomicrograph. Myotube formation was only scored based on morphology using phase contrast microscopy.
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accompany the culture of primary human MSC. 54 Altered integrin expression on HSC in the mouse is also associated with their mobilization and presumably significantly affects the engraftment potential of HSC. 55 The elucidation of such changes within the MSC compartment would require their homogenous purification, which is still elusive in the murine model. Alternatively, to investigate the role of homing molecules a transplantation model could be established, using either transgenic mice or knock-out mice in which the expression of homing molecules is modified. A third approach to prevent sequestration of cultured MSC following their transplantation could be changing the culture support or the addition of specific growth factors to the medium so as to circumvent this potentially aberrant expression of homing molecules. Another possibility which cannot be excluded is that, analogous to the hematopoietic system, [56] [57] [58] only cells in the G0 phase of the cell cycle are able to permanently lodge in their respective niches, after which these cells are able to expand and reconstitute the host. Even short-term culture may induce the progression of quiescent cells (G0 of cell cycle) into G1 or even later stages of the cell cycle, resulting in a lost or diminished in vivo repopulating capacity.
Interestingly, the majority of the MSC that was cultured for 24-48 h was not adherent, ie 75 to 90% of the MSC retrieved were present in the non-adherent fraction of the cultures. This observation seems to be at difference with the established notion that MSC are typically adherent cells. 12, 59 It may also explain the fact that we report higher CFU-F frequencies than reported by some other investigators. 36, 60 In the study by Kuznetsov and Gehron Robey 60 the cells were allowed to adhere for 2.5 to 3 h after which the non-adherent cells were removed. Using these conditions they observed a CFU-F frequency for mouse bone marrow of 1.0 ± 04 per 10 6 cells. Phinney et al 36 removed the non-adherent cells after 72 h. Using several different mouse strains they calculated a bone marrow CFU-F frequency varying from 3.0 ± 0.22 (Balb/c) to 0.3 ± 0.22 (C57bl/6) per 10 6 cells plated. These results are in contrast to the bone marrow CFU-F frequency of 35 ± 4 per 10 6 cells plated that we observed without removal of the nonadherent cells (Table 3) . However, if we correct the number of CFU-F in the adherent fractions after 24 and 48 h of culture for the numbers of nucleated cells used to initiate these cultures, the calculated CFU-F frequencies of 1.9 ± 0.1 and 6.5 ± 1.3 per 10 6 cells, respectively, would be much more in line with the data of the referred authors. Also, whilst Phinney et al only scored colonies with a diameter of more than 2 mm, we (as well as Kuznetzov) scored colonies containing more Unseparated murine bone marrow from EGFP-transgenic mice was cultured in vitro for 24 or 48 h, after which the total number of nucleated cells and CFU-F was determined for both the adherent and the non-adherent fractions of the cultures. Samples from both fractions were injected in 7 Gy irradiated syngeneic wild-type C57Bl/6 mice. After 72 h these mice were killed and the number of donor-derived CFU-F in spleen and bone marrow was assayed using a secondary CFU-F assay. Data presented are the mean ± 1 s.e.m. of three individual experiments. a One single colony was observed in a total of nine dishes analyzed. b Colonies are significantly reduced in cellularity when compared to colonies derived from uncultured full bone marrow.
than 50 fibroblastoid cells. As many of these colonies are Ͻ2 mm in diameter this would result in a higher number of CFU-F compared to the method used by Phinney et al. In summary, our data clearly demonstrate that: (1) highly efficient homing and regeneration of primary donor-derived MSC in bone marrow and spleen can be observed; (2) host preconditioning is necessary for an efficient homing and expansion of primary murine MSC; (3) murine MSC can be cultured and expanded in vitro with maintenance of both in vitro differentiation ability and the ability to form CFU-F, but rapidly lose their in vivo homing ability.
